SEC 13F Intelligence

Duquesne Family Office LLC / XENE

Duquesne Family Office LLC’s Xenon Pharmaceuticals Inc Position

Does Duquesne Family Office LLC own Xenon Pharmaceuticals Inc (XENE)? Yes238.6K shares worth $14M (+0.41% of its 13F portfolio) as of Q1 2026.

Position Value
$14M
Q1 2026
Shares
238.6K
% of Portfolio
+0.41%
Quarters Held
1
currently held

Position History XENE

Reported value by quarter
Q1 ’26: $14MQ1 ’26filingsflow.com
QuarterSharesValue% of Portfolio
Q1 2026238.6K$14M+0.41%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Duquesne Family Office LLC’s full portfolio or all institutional holders of XENE.